Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HALO | APLS | CRSP | ||
| Company | Halozyme Therapeutic | Apellis Pharmaceuticals Inc | Crispr Therapeutics Ag | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 39.56 | 46.62 | 54.48 | ||
| High | 39.69 | 47.74 | 55.34 | ||
| Low | 38.88 | 46.10 | 53.99 | ||
| Last | 39.85 | 47.47 | 54.71 | ||
| Change | +0.55 | +1.42 | +0.90 | ||
| % Change | +1.40% | +3.08% | +1.67% | ||
| Volume | 77,621 | 179,919 | 287,162 | ||
| 20-Day Average Volume | 828,162 | 1,536,467 | 1,270,711 | ||
| Previous Close | 39.30 | 46.05 | 53.81 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 38.97 | 50.26 | 57.62 | ||
| 20-Day Raw Stochastic | 48.81% | 46.51% | 13.27% | ||
| 20-Day Relative Strength | 52.41% | 39.90% | 34.73% | ||
| Weighted Alpha | +21.78 | -20.50 | -21.09 | ||
| Today's Opinion | 40% Buy | 56% Sell | 40% Sell | ||
| Previous Opinion | 40% Buy | 56% Sell | 40% Sell | ||
| Last Month's Opinion | 56% Buy | 8% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.89% since 04/25/24 | -1.21% since 04/25/24 | +1.23% since 04/25/24 | ||
| Low | 37.97 on 04/30/24 | 38.22 on 04/30/24 | 52.73 on 04/30/24 | ||
| High | 40.00 on 05/01/24 | 50.98 on 04/26/24 | 55.97 on 05/01/24 | ||
| 1-Month | |||||
| %Chg | -2.13% since 04/02/24 | -14.99% since 04/02/24 | -16.36% since 04/02/24 | ||
| Low | 37.73 on 04/19/24 | 38.22 on 04/30/24 | 52.73 on 04/30/24 | ||
| High | 41.50 on 04/05/24 | 58.12 on 04/04/24 | 67.25 on 04/04/24 | ||
| 3-Month | |||||
| %Chg | +17.49% since 02/02/24 | -24.31% since 02/02/24 | -16.00% since 02/02/24 | ||
| Low | 33.15 on 02/05/24 | 38.22 on 04/30/24 | 52.73 on 04/30/24 | ||
| High | 42.64 on 03/13/24 | 71.90 on 02/26/24 | 91.10 on 02/22/24 | ||
| 6-Month | |||||
| %Chg | +15.53% since 11/02/23 | -3.99% since 11/02/23 | +17.78% since 11/02/23 | ||
| Low | 33.15 on 02/05/24 | 38.22 on 04/30/24 | 47.50 on 11/03/23 | ||
| High | 42.82 on 12/14/23 | 73.80 on 01/09/24 | 91.10 on 02/22/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,993,222 | 5,585,588 | 4,567,555 | ||
| Shares Outstanding, K | 127,054 | 121,294 | 84,883 | ||
| Annual Sales | 829,250,000 | 396,590,000 | 371,210,000 | ||
| Annual Net Income | 281,590,000 | -528,630,000 | -153,610,000 | ||
| Last Quarter Sales | 230,040,000 | 146,380,000 | 201,210,000 | ||
| Last Quarter Net Income | 85,390,000 | -88,580,000 | 89,350,000 | ||
| 60-Month Beta | 1.26 | 0.97 | 1.80 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.82 on 02/20/24 | -0.73 on 02/27/24 | 1.10 on 02/21/24 | ||
| Latest Earnings Date | 05/07/24 | 05/07/24 | 05/13/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 14.94 | 0.00 | 0.00 | ||